TrialEBioMedicine2017

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.

Odile Launay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.